Mufg Americas Holdings Corp Regenxbio Inc. Transaction History

Mufg Americas Holdings Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 07, 2018	SELL	$24.05 - $37.5 $3,727 - $5,812	-155 Reduced 24.68%	473 $14,000
Q4 2017 Feb 08, 2018	SELL	$26.0 - $34.6 $5,200 - $6,920	-200 Reduced 24.15%	628 $0
Q3 2017 Nov 13, 2017	BUY	$18.0 - $32.95 $324 - $593	18 Added 2.22%	828 $0
Q2 2017 Aug 07, 2017	BUY	N/A	810	810 $0

186

43.1M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $349M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Mufg Americas Holdings Corp, based on Form 13F filings with the SEC.

Stay updated on Mufg Americas Holdings Corp with notifications on news.